Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Other Non Operating Income (2020 - 2025)

Tango Therapeutics (TNGX) has 6 years of Other Non Operating Income data on record, last reported at $910000.0 in Q2 2025.

  • For Q2 2025, Other Non Operating Income fell 54.39% year-over-year to $910000.0; the TTM value through Jun 2025 reached $5.4 million, down 30.16%, while the annual FY2025 figure was $4.1 million, 46.54% down from the prior year.
  • Other Non Operating Income reached $910000.0 in Q2 2025 per TNGX's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.2 million in Q1 2024 and bottomed at -$81000.0 in Q4 2021.
  • Average Other Non Operating Income over 5 years is $932444.4, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: plummeted 1350.0% in 2021, then skyrocketed 2689.36% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at -$81000.0 in 2021, then soared by 1293.83% to $967000.0 in 2022, then skyrocketed by 113.13% to $2.1 million in 2023, then dropped by 28.38% to $1.5 million in 2024, then plummeted by 38.35% to $910000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $910000.0 in Q2 2025, $1.1 million in Q1 2025, and $1.5 million in Q4 2024.